Evidence map›Paper›PMID 40046066›Full record

ArticleJAC-antimicrobial resistance2025

National expert consensus on the management of antibiotic prophylaxis in surgical patients with a penicillin allergy label based on the Delphi method.

Aurélie Gouel-Chéron, Catherine Neukirch, Annick Barbaud, Axelle Dupont, Jean-Ralph Zahar, Solen Kernéis, Marc Garnier, Gabriel Birgand, Sara Romano-Bertrand, Philippe Lesprit and 10 more

Abstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Aurélie Gouel-ChéronParis Cité University, Paris, France.ORCID https://orcid.org/0000-0003-2648-1693
Catherine NeukirchService de Pneumologie A, APHP Hôpital Bichat, Paris, France.ORCID https://orcid.org/0000-0002-0778-4165
Annick BarbaudDepartment of Dermatology and Allergology, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, AP-HP Sorbonne Universite, Tenon Hopital, Paris, France.ORCID https://orcid.org/0000-0001-8889-1589
Axelle DupontClinical Research, Biostatistics and Epidemiology Department, AP-HP Nord, Paris, France.ORCID https://orcid.org/0000-0002-1067-0214
Jean-Ralph ZaharIAME UMR 1137, INSERM, Université Paris-Cité, Paris, France.ORCID https://orcid.org/0000-0002-4228-3868
Solen KernéisINSERM, IAME, Université Paris Cité, Paris F-75018, France.ORCID https://orcid.org/0000-0001-8064-7987
Marc GarnierDépartement d'anesthésie-réanimation et médecine périopératoire, CHU de Clermont-Ferrand, Clermont-Ferrand, France.ORCID https://orcid.org/0000-0002-5716-4239
Gabriel BirgandRegional Center for Infection Prevention and Control Pays de la Loire, Centre Hospitalier Universitaire de Nantes, Nantes, France.ORCID https://orcid.org/0000-0002-5371-2808
Sara Romano-BertrandHospital Hygiene and Infection Control Team, University Hospital of Montpellier, Montpellier 34093, France.ORCID https://orcid.org/0000-0002-6134-2210
Philippe LespritService des Maladies Infectieuses et Tropicales, CHU Grenoble Alpes, Grenoble, France.ORCID https://orcid.org/0000-0002-2407-7972
Sylvain DiamantisService des Maladies Infectieuses et Tropicales, GHSIF, Melun, France.ORCID https://orcid.org/0000-0001-6272-4707
Remy GauzitInfectiologie Transversale, CHU Cochin, AP-HP, Paris 75014, France.ORCID https://orcid.org/0000-0001-6946-5541
Estelle MarcaultClinical Research, Biostatistics and Epidemiology Department, AP-HP Nord, Paris, France.
Marc LeoneDepartment of Anaesthesiology and Intensive Care Unit, Nord Hospital, Assistance Publique Hôpitaux Universitaires de Marseille, Aix Marseille Université, Marseille, France.ORCID https://orcid.org/0000-0002-3097-758X
Matthieu BoissonUFR de Médicine et Pharmacie, INSERM U1070, PHAR2, Université de Poitiers, Poitiers, France.ORCID https://orcid.org/0000-0003-3667-5782
Claire RogerUR-UM103 IMAGINE, Univ Montpellier, Division of Anaesthesia and Critical Care, Pain and Emergency Medicine, Nîmes University Hospital, Montpellier, France.ORCID https://orcid.org/0000-0002-6055-0034
Claire Dahyot-FizelierUFR de Médicine et Pharmacie, INSERM U1070, PHAR2, Université de Poitiers, Poitiers, France.ORCID https://orcid.org/0000-0002-3933-0619
Pascal DemolyDepartment of Pulmonology, Division of Allergy, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, IDESP, University of Montpellier, Montpellier, France.ORCID https://orcid.org/0000-0001-7827-7964
Anca ChiriacDepartment of Pulmonology, Division of Allergy, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, IDESP, University of Montpellier, Montpellier, France.ORCID https://orcid.org/0000-0002-1558-1966
Philippe MontraversParis Cité University, Paris, France.ORCID https://orcid.org/0000-0002-3422-5705

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with a penicillin allergy label have an increased risk of surgical site infection. Although a decision tree was published in 2019 to define which patients could benefit from direct cephalosporin use in the perioperative setting, this strategy remains unvalidated. This consensus statement aimed to adapt it based on an expert consensus to cover persisting caveats and to adapt it to an environment with poor allergist resources. Methods: Perioperative antibiotic prophylaxis and allergy experts were invited to participate. The Delphi method was implemented using an online-secured network. The panellists were given 3 weeks to answer each round. A consensus was reached if more than 75% of the experts rated the item ≥ 7 and if less than 25% rated the item ≤ 3. Results: Sixteen experts participated. A high level of agreement was obtained after four rounds, defining four categories of the index reaction: unknown, not compatible, or compatible with an immediate or delayed hypersensitivity reaction. Twelve items were defined to stratify the risk of true penicillin allergy according to the index reaction history. The experts agreed that patients with high-risk reactions could benefit from either an allergy work-up or beta-lactam alternatives use. Those at low risk could benefit from direct cephalosporin administration. Conclusions: This resulted in an adapted decision tree to promote cephalosporin prescription in patients with penicillin allergy labels. It will be used in a stepped-wedge prospective multicentric randomized study to assess its applicability and acceptability to promote first- and second-generation cephalosporin administration in the perioperative period.

Identifiers

PMID40046066
PMCPMC11880800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.